ArticleEuropean journal of pediatrics2026
Oral aphthosis in children: baseline clinical features associated with diagnostic categories in a single-centre retrospective cohort.
Article in European journal of pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We examined associations between clinical features at first paediatric rheumatology assessment and eventual benign/self-limited (Group 1) versus systemic/chronic (Group 2) diagnostic categories in children referred for recurrent oral aphthosis. We retrospectively studied 404 children evaluated from 2010 to 2024. Baseline clinical variables were documented at the first rheumatology visit before final diagnosis; follow-up assessments were performed every 3-6 months. Eight prespecified clinical features entered multivariable logistic regression. Firth and diagnosis-exclusion sensitivity analyses addressed sparse data and diagnostic-composition bias. CRP/ESR and HLA-B51 were analysed separately. The cohort included 198 males (49.0%) and 206 females (51.0%); age at symptom onset ranged from 2 months to 15 years. Group 1 included 267 patients, and Group 2 included 137. Recurrent fever (aOR, 0.25; 95% CI, 0.12-0.49) and tonsillitis/pharyngitis (aOR, 0.17; 95% CI, 0.09-0.32) were associated with lower odds of Group 2, whereas genital aphthosis was associated with higher odds (aOR, 13.08; 95% CI, 3.04-56.32). After simultaneous exclusion of PFAPA and Behçet disease spectrum diagnoses, the fever/pharyngitis associations were attenuated, and the genital aphthosis estimate became uninformative because of sparse data, while arthralgia/arthritis remained positively associated. Elevated CRP/ESR was not independently associated with Group 2; HLA-B51 positivity was more frequent in Group 2 among selectively tested patients.
conclusionIn children referred for recurrent oral aphthosis, recurrent fever and pharyngitis were mainly associated with benign/self-limited diagnoses, whereas genital aphthosis was mainly associated with systemic/chronic diagnoses. These associations were largely driven by PFAPA and Behçet spectrum disease, respectively. Articular involvement showed the most consistent positive association across sensitivity analyses. These findings are descriptive, not a validated diagnostic prediction tool. WHAT IS KNOWN: • Oral aphthae are common and non-specific in childhood. • Associated symptoms guide diagnostic work-up and follow-up. WHAT IS NEW: • PFAPA-characteristic features clustered with benign/self-limited diagnoses; genital aphthosis with systemic/chronic diagnoses. • After PFAPA/Behçet spectrum exclusion, these signals attenuated; articular involvement was the most consistent positive association.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.